Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,564 | 241 | 99.5% |
| Education | $21.70 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,064 | 60 | $0 (2024) |
| Merck Sharp & Dohme LLC | $878.02 | 42 | $0 (2024) |
| Amgen Inc. | $645.25 | 35 | $0 (2024) |
| Amarin Pharma Inc. | $505.79 | 26 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $382.21 | 20 | $0 (2024) |
| Novo Nordisk Inc | $177.88 | 9 | $0 (2022) |
| Gilead Sciences, Inc. | $173.76 | 11 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $165.57 | 8 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $160.15 | 9 | $0 (2020) |
| Nestle HealthCare Nutrition Inc. | $56.20 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.45 | 28 | Merck Sharp & Dohme LLC ($212.17) |
| 2023 | $593.54 | 31 | Merck Sharp & Dohme LLC ($209.82) |
| 2022 | $742.24 | 36 | Merck Sharp & Dohme LLC ($241.76) |
| 2021 | $935.21 | 46 | Amarin Pharma Inc. ($236.43) |
| 2020 | $292.48 | 15 | Novartis Pharmaceuticals Corporation ($124.31) |
| 2019 | $671.49 | 36 | Amarin Pharma Inc. ($228.56) |
| 2018 | $462.92 | 27 | Novartis Pharmaceuticals Corporation ($152.89) |
| 2017 | $368.46 | 23 | Novartis Pharmaceuticals Corporation ($162.36) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: DIABETES | ||||||
| 08/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: DIABETES | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: DIABETES | ||||||
| 05/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: DIABETES | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: DIABETES | ||||||
| 04/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Cardiology | ||||||
| 03/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: DIABETES | ||||||
| 02/12/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 869 | 1,261 | $251,690 | $113,291 |
| 2022 | 15 | 830 | 1,234 | $246,709 | $108,769 |
| 2021 | 15 | 770 | 1,083 | $206,385 | $91,381 |
| 2020 | 16 | 657 | 809 | $153,279 | $63,952 |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 303 | $60,610 | $32,450 | 53.5% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 51 | 60 | $22,000 | $13,056 | 59.3% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 40 | 47 | $16,487 | $11,444 | 69.4% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 141 | 153 | $28,360 | $9,059 | 31.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 53 | 63 | $16,825 | $8,971 | 53.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 53 | 62 | $22,500 | $8,959 | 39.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 38 | 43 | $10,450 | $7,191 | 68.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 30 | 31 | $9,161 | $5,126 | 56.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $7,320 | $4,416 | 60.3% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 48 | 56 | $14,000 | $4,390 | 31.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 96 | 167 | $5,310 | $1,872 | 35.2% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 52 | 61 | $21,350 | $1,329 | 6.2% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Office | 2023 | 48 | 56 | $11,200 | $1,303 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $1,752 | $1,227 | 70.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 15 | $1,500 | $1,176 | 78.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 25 | 26 | $825.31 | $751.92 | 91.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 45 | 68 | $2,040 | $571.20 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 320 | $61,256 | $35,157 | 57.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2022 | 49 | 56 | $19,650 | $13,375 | 68.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 134 | 153 | $31,800 | $11,143 | 35.0% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2022 | 48 | 55 | $19,450 | $8,869 | 45.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 49 | 56 | $14,840 | $8,500 | 57.3% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2022 | 27 | 29 | $10,150 | $7,603 | 74.9% |
| 93308 | Ultrasound of heart, follow-up | Office | 2022 | 65 | 75 | $18,750 | $5,793 | 30.9% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 26 | 29 | $7,186 | $5,212 | 72.5% |
About Dr. Derek Sun, M.D
Dr. Derek Sun, M.D is a Cardiovascular Disease healthcare provider based in Flushing, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831267087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Derek Sun, M.D has received a total of $4,586 in payments from pharmaceutical and medical device companies, with $519.45 received in 2024. These payments were reported across 242 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,564).
As a Medicare-enrolled provider, Sun has provided services to 3,126 Medicare beneficiaries, totaling 4,387 services with total Medicare billing of $377,392. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Flushing, NY
- Active Since 12/04/2006
- Last Updated 03/09/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1831267087
Products in Payments
- ENTRESTO (Drug) $868.80
- VERQUVO (Drug) $712.93
- Vascepa (Drug) $505.79
- Repatha (Biological) $473.19
- JARDIANCE (Drug) $340.52
- LEQVIO (Drug) $194.79
- XARELTO (Drug) $165.57
- XIFAXAN (Drug) $160.15
- Ozempic (Drug) $133.69
- Corlanor (Drug) $116.35
- JANUVIA (Drug) $105.10
- STEGLATRO (Drug) $59.99
- ZENPEP (Drug) $56.20
- Prolia (Biological) $55.71
- NEXLETOL (Drug) $53.14
- Inpefa (Drug) $45.74
- Rybelsus (Drug) $44.19
- PRADAXA (Drug) $41.69
- TRULICITY (Drug) $41.35
- ELIQUIS (Drug) $28.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Flushing
Madar Abed, Md, MD
Cardiovascular Disease — Payments: $98,164
Dr. Joseph Ma, Md, MD
Cardiovascular Disease — Payments: $18,815
Dr. Jiong-Ming Hu, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $16,826
Dr. Wai Leung, M.d, M.D
Cardiovascular Disease — Payments: $15,212
Dr. Thomas Chen, M.d, M.D
Cardiovascular Disease — Payments: $12,856
Chong Park, Md, MD
Cardiovascular Disease — Payments: $12,111